In the US, Rifadin (rifampin systemic) is a member of the drug class rifamycin derivatives and is used to treat Bartonellosis, Endocarditis, Haemophilus influenzae Prophylaxis, Legionella Pneumonia, Leprosy, Leprosy - Borderline, Leprosy - Tuberculoid, Meningitis, Meningococcal Meningitis Prophylaxis, Nasal Carriage of Staphylococcus aureus, Tuberculosis - Active, Tuberculosis - Latent and Tuberculosis - Prophylaxis.
- RIFADIN 100MG/5ML ORAL SUSPENSION (Leaflet)
- RIFADIN 150MG CAPSULES (Leaflet)
- RIFADIN 300MG CAPSULES (Leaflet)
- RIFADIN 600MG INFUSION (Leaflet)
- RIFADIN FOR INFUSION 600MG (Leaflet)
- RIFADIN SYRUP 100MG/5ML (Leaflet)
Ingredient matches for Rifadin
Rifampicin is reported as an ingredient of Rifadin in the following countries:
- Hong Kong
- New Zealand
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.